Products
Platform
Research
Market
Learn
Dr Reddys Laboratories Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 9,152.20 | 8,862.40 | 9,050.50 | 8,531.40 | 8,345.70 |
| Other Income Qtr Cr | 323.90 | 290.30 | 522.10 | 150.20 | 307.50 |
| Operating Revenues Qtr | 8,828.30 | 8,572.10 | 8,528.40 | 8,381.20 | 8,038.20 |
Loading chart... | |||||
Operating Expenses Qtr | 6,818.40 | 6,398.50 | 6,453.70 | 6,108.20 | 5,961.70 |
Operating Profit Qtr | 2,009.90 | 2,173.60 | 1,997.90 | 2,273.00 | 2,076.50 |
EBITDA Qtr Cr | 2,333.80 | 2,463.90 | 2,520.00 | 2,423.20 | 2,384.00 |
Depreciation Qtr | 504.60 | 476.10 | 454.70 | 471.40 | 397.00 |
Net Profit Qtr | 1,347.10 | 1,418.10 | 1,593.30 | 1,413.70 | 1,255.70 |
Basic EPS Qtr | 16.18 | 17.04 | 19.12 | 16.97 | 80.45 |
Open Demat Account
Open Demat Account